GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JBM (Healthcare) Ltd (HKSE:02161) » Definitions » Price-to-Owner-Earnings

JBM (Healthcare) (HKSE:02161) Price-to-Owner-Earnings : 14.17 (As of May. 31, 2025)


View and export this data going back to 2021. Start your Free Trial

What is JBM (Healthcare) Price-to-Owner-Earnings?

As of today (2025-05-31), JBM (Healthcare)'s share price is HK$2.55. JBM (Healthcare)'s Owner Earnings per Share (TTM) ended in Mar. 2024 was HK$0.18. It's Price-to-Owner-Earnings for today is 14.17.


The historical rank and industry rank for JBM (Healthcare)'s Price-to-Owner-Earnings or its related term are showing as below:

HKSE:02161' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 4.89   Med: 8.6   Max: 17.07
Current: 14.49

During the past 7 years, the highest Price-to-Owner-Earnings of JBM (Healthcare) was 17.07. The lowest was 4.89. And the median was 8.60.


HKSE:02161's Price-to-Owner-Earnings is ranked better than
71.14% of 447 companies
in the Drug Manufacturers industry
Industry Median: 25.25 vs HKSE:02161: 14.49

As of today (2025-05-31), JBM (Healthcare)'s share price is HK$2.55. JBM (Healthcare)'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was HK$0.20. Therefore, JBM (Healthcare)'s PE Ratio (TTM) for today is 13.08.

As of today (2025-05-31), JBM (Healthcare)'s share price is HK$2.55. JBM (Healthcare)'s EPS without NRI for the trailing twelve months (TTM) ended in was HK$0.19. Therefore, JBM (Healthcare)'s PE Ratio without NRI for today is 13.49.

During the past 7 years, JBM (Healthcare)'s highest PE Ratio without NRI was 76.79. The lowest was 6.01. And the median was 22.14.


JBM (Healthcare) Price-to-Owner-Earnings Historical Data

The historical data trend for JBM (Healthcare)'s Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JBM (Healthcare) Price-to-Owner-Earnings Chart

JBM (Healthcare) Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - 15.69 7.55 5.40

JBM (Healthcare) Semi-Annual Data
Mar18 Mar19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 7.55 - 5.40 -

Competitive Comparison of JBM (Healthcare)'s Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, JBM (Healthcare)'s Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JBM (Healthcare)'s Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JBM (Healthcare)'s Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where JBM (Healthcare)'s Price-to-Owner-Earnings falls into.


;
;

JBM (Healthcare) Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

JBM (Healthcare)'s Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=2.55/0.18
=14.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JBM (Healthcare)  (HKSE:02161) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


JBM (Healthcare) Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of JBM (Healthcare)'s Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


JBM (Healthcare) Business Description

Traded in Other Exchanges
N/A
Address
108 Wai Yip Street, Units 808-811, 8 floor, C-Bons International Centre, Kwun Tong, Kowloon, Hong Kong, HKG
JBM (Healthcare) Ltd markets and distributes healthcare products. The company's operating segment includes Branded medicines; Proprietary Chinese medicines and Health and wellness products. It generates maximum revenue from the Proprietary Chinese medicines segment. The Proprietary Chinese medicines segment develops, manufactures, and distributes registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal, or mineral origin customarily or widely used by the Chinese. Geographically, it derives a majority of its revenue from Hong Kong.
Executives
Sum Kwong Yip, Derek
Queenshill Development Limited
Ubs Trustees (b.v.i.) Limited
Kingshill Development Group Inc
Lincoln's Hill Development Limited
Yun Nan Bai Yao Ji Tuan Gu Fen You Xian Gong Si
New Heritage Healthcare Limited 2101 Beneficial owner
Gavett Limited 2201 Interest of corporation controlled by you
United Islands Group Limited 2201 Interest of corporation controlled by you
Fortstar Limited 2201 Interest of corporation controlled by you
Tao Richard 2201 Interest of corporation controlled by you
Hon Hing Tong Patricia 2202 Interest of your spouse
Tao Paul 2201 Interest of corporation controlled by you
Choi Siu Ping 2202 Interest of your spouse
Longjin Investments Limited 2101 Beneficial owner

JBM (Healthcare) Headlines

No Headlines